Fig. 1From: Differences in outcomes of hospitalizations for heart failure after SGLT2 inhibitor treatment: effect modification by atherosclerotic cardiovascular diseaseThe risk of hospitalization due to heart failure between dapagliflozin new users and empagliflozin new users, matched by propensity scoreBack to article page